World Cancer, Oncology and Therapeutics Congress:Tumoral Pyruvate Kinase L/R as a Predictive Marker for the Treatment of Renal C
![Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type - eBioMedicine Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type - eBioMedicine](https://www.thelancet.com/cms/attachment/8d822e4c-bead-411e-9593-eebccce58297/gr1_lrg.jpg)
Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type - eBioMedicine
Interleukin-15 Plays a Central Role in Human Kidney Physiology and Cancer through the γc Signaling Pathway | PLOS ONE
![PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a4e05d7535a89c3cb99b3260ff7b3a9b05568fd2/9-Figure3-1.png)
PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar
![PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a4e05d7535a89c3cb99b3260ff7b3a9b05568fd2/6-Figure2-1.png)
PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar
![Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821001173-fx1.jpg)
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect
![MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma | Nature Communications MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncomms15770/MediaObjects/41467_2017_Article_BFncomms15770_Fig1_HTML.jpg)
MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma | Nature Communications
![IJMS | Free Full-Text | The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory? | HTML IJMS | Free Full-Text | The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory? | HTML](https://www.mdpi.com/ijms/ijms-22-06237/article_deploy/html/images/ijms-22-06237-g001.png)
IJMS | Free Full-Text | The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory? | HTML
![Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma - ScienceDirect Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610821005432-fx1.jpg)
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma - ScienceDirect
![PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a4e05d7535a89c3cb99b3260ff7b3a9b05568fd2/5-Figure1-1.png)
PDF] Immunohistochemical markers in renal tumors and findings in non-tumoral renal parenchyma | Semantic Scholar
![Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness - Momoi - 2021 - Cancer Science - Wiley Online Library Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness - Momoi - 2021 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4f8ecf0b-1061-4c29-b12b-7167db517157/cas15007-fig-0006-m.jpg)
Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness - Momoi - 2021 - Cancer Science - Wiley Online Library
Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib
![Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma | SpringerLink Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-021-03018-4/MediaObjects/428_2021_3018_Fig2_HTML.png)
Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma | SpringerLink
![Diagnostics | Free Full-Text | Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies | HTML Diagnostics | Free Full-Text | Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies | HTML](https://www.mdpi.com/diagnostics/diagnostics-11-01187/article_deploy/html/images/diagnostics-11-01187-g001.png)
Diagnostics | Free Full-Text | Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies | HTML
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.tbl1.png)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610820305420-fx1.jpg)